NCATS-supported scientists are engaged in cutting-edge translational research activities across the United States. Read the latest news about CTSA Program researchers that are collaborating locally, regionally and nationally, fostering innovation in training and methodologies to get more treatments to more patients more quickly.
Learn more about the CTSA Program in Action:
- Goal 1: Train and Cultivate the Translational Science Workforce
- Goal 2: Engage Patients and Communities in Every Phase of the Translational Process
- Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan
- Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials
- Goal 5: Advance the Use of Cutting-Edge Informatics
Through the NCATS-Eli Lilly externship, CTSA Program Scholar Josephine Taverna, M.D., learns new approaches to drive her research forward.
- NIH Collaboration Leverages CTSA Program for Research Mentoring
- CTSA Program Collaboration Aims to Improve Brain Cancer Drug Testing
- CTSA Program Mentoring Helps Engineers Develop Innovative Rehabilitation Therapies
The CTSA Program hub at the University of Rochester has launched a pilot study to develop and test a community engagement assessment tool to help academic health centers evaluate and enhance their work.
- NCATS-Supported Researchers Demonstrate Value in Community-Based Research Consultation Service
- NCATS Enables Scientists, Community Clinicians to Collaborate on Health Initiatives
- CTSA Program Hub Expands Successful Radio Show with Podcast
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research across the Human Lifespan
Efforts are now underway to add rare diseases to newborn screenings through Early Check, a research program in which voluntary screening for fragile X syndrome and other genetic conditions yet to be determined will be offered to up to 120,000 families each year in North Carolina. NCATS is supporting Early Check through a CTSA Program Collaborative Innovation Award (CCIA).
- Unprecedented Trans-NCATS Collaboration Enables Rapid Advancement of Rare Lung Disease Therapy to Human Trials
- CTSA Program-Supported Research Uncovers Genetic Components of Healthy Aging
- CTSA Program Supports Research Network in Geographically Isolated Region
Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials
Researchers at the University of California, Los Angeles, supported in part by NCATS' CTSA Program, discovered a troubling opioid prescribing trend. Patients who took a type of anti-anxiety medicine were more than twice as likely as the general public to receive new opioid prescriptions despite a higher overdose risk.
- CTSA Program Support May Lead to Blood Test for Colon Cancer Screening
- New Study Shows Medication-Based Treatment After Opioid Overdose Can Save Lives
- CTSA Program Researchers Advance Heart Condition Study Through Precision Medicine and Digital Health
NCATS established the National Center for Data to Health to develop standardized approaches and best practices that address operational and institutional barriers to sharing data.
- Improving Patient-Reported Outcome Data for Research through Seamless Integration of the PROMIS Toolkit and Computer-Adaptive Testing Modules into EHR Workflow
- NCATS Supports Novel Methods to Improve Institutional Review Board Efficiencies
- NCATS-Supported Researchers Recruit Citizen Scientists to Help Mine Biomedical Literature